… 4. HAART In the early 1980s, cases of Acquired Immune Deficiency Syndrome (AIDS) were rising and, by the 1990s, millions of people were infected and dying. Dr. Julio Montaner, originally from Argentina, became a post-doctoral fellow at the University of British Columbia in 1981. Six years later, Dr. Montaner became the university’s director of
El 1o de diciembre, el “DÃa Mundial del SIDA”, mientras reflexionamos sobre el grave impacto del VIH/SIDA en los últimos 40 años, nos encontramos frente a un precipicio donde todos los avances que hemos logrado están en peligro. La marea comenzó a cambiar en contra de la epidemia de VIH/SIDA cuando anunciamos el cóctel de
In adults, initial infection with syphilis can cause a small painless and temporary sore, sometimes on the genitals. As this sore can also occur inside the mouth or ano-genital tract, it can go unnoticed. After initial infection with this sexually transmitted infection (STI), the germs that cause syphilis can quickly spread throughout the body. If
Dr. Julio Montaner discusses HIV/AIDS, where we are at in treatment, where we need to go and what roadblocks still need to be removed In 1996, Dr. Julio Montaner hosted the Vancouver International AIDS Conference and shared the HAART antiretroviral treatment he and a team of committed scientists was pioneering in Vancouver. Since then, he
El 1o de diciembre, el “Día Mundial del SIDA”, mientras reflexionamos sobre el grave impacto del VIH/SIDA en los últimos 40 años, nos encontramos frente a un precipicio donde todos los avances que hemos logrado están en peligro. La marea comenzó a cambiar en contra de la epidemia de VIH/SIDA cuando anunciamos el cóctel de
Adrian Dix, Minister of Health, has issued the following statement in recognition of World AIDS Day and Indigenous AIDS Awareness Week: “Dec. 1 marks World AIDS Day and the beginning of Indigenous AIDS Awareness Week. It is time to renew our collective and personal commitment to supporting British Columbians living with HIV/AIDS and ensuring that
Hace casi cuatro décadas que el médico argentino trabaja en una solución para erradicar una de las peores epidemias de la historia de la humanidad. Su camino en busca de una cura deja día a día una huella profunda en la comunidad política y científica de todo el mundo. A principios de la década del
December 1 is World AIDS Day and the start of Indigenous AIDS Awareness Week in Canada. For our latest vodcast episode, President of Doctors of BC, Dr Ramneek Dosanjh, speaks with three guests in the area of HIV/AIDS including: They discuss what doctors should know about HIV/AIDS and how they can promote equality around testing,
Dec. 1 marks World AIDS Day. As researchers focused on fighting the HIV-AIDS epidemic, we are increasingly concerned all the progress made in the fight against the virus is at risk. In 1996, the first remarkable breakthrough against the HIV-AIDS epidemic came with the novel combination of drugs that became known as Highly Active Antiretroviral
He devoted himself to improving the care and treatment for people with HIV/AIDS and his work saved millions of lives around the world. Julio Montaner: Excellence in HIV/AIDS research from Conversations That Matter on Vimeo.
He devoted himself to improving the care and treatment for people with HIV/AIDS and his work saved millions of lives around the world.
I have been living with HIV (Human Immunodeficiency Virus) for 38 years, and have had an undetectable viral load (less than 40 copies/mL) since 1998. Both of these facts are possible because of activism, community care, and HIV medications. BC has been my home for 28 years. I chose to live here because this province,
A CITF-funded study, published in preprint, and not yet peer-reviewed, from Mark Brockman and Zabrina Brumme (Simon Fraser University and BC Centre for Excellence in HIV/AIDS), along with Drs. Aslam Anis and Marc Romney (University of British Columbia) showed that the antibody responses induced by a third dose of COVID-19 vaccine were as durable in
Preliminary results from a survey of stigma and discrimination conducted by the European Centre for Disease Prevention and Control (ECDC) show that people living with HIV in Europe are as likely to have experienced stigma in recent years as they were a decade ago. This is particularly the case with some types of stigma experienced in healthcare settings,
For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important element in the equation. So says Dr. Ole Schmeltz Søgaard, Professor of Translational Viral Research at Aarhus University,
Following years of oral PrEP’s slow uptake, a new innovation is generating excitement around the highly effective drug The HIV prevention medication PrEP was called a game-changer, superpower and major breakthrough in the global effort toward zero new HIV transmissions when it first hit Canadian markets six years ago. Big praise, and steep expectations, for
Study published Friday shows that virus spiked as people had less access to services in early 2020 A new study says reduced access to HIV services amid early COVID-19 closures in British Columbia was associated with a “sharp increase” in HIV transmission among some drug users. The study by University of British Columbia researchers says that
A new study led by researchers at UBC and the BC Centre for Excellence in HIV/AIDS (BC-CfE) is shedding light on how COVID-19 pandemic restrictions impacted another long-standing public health threat — HIV. The study, published in the Lancet Regional Health – Americas, examined HIV transmission during B.C.’s initial COVID-19 lockdown (March 22 to May
A new study led by researchers at UBC and the BC Centre for Excellence in HIV/AIDS (BC-CfE) is shedding light on how COVID-19 pandemic restrictions impacted another long-standing public health threat – HIV. The study, published in the Lancet Regional Health – Americas, examined HIV transmission during B.C.’s initial COVID-19 lockdown (March 22 to May
Health Research BC’s funding for 71 researchers through the 2022 Scholar and Research Trainee competitions will help develop, attract and retain BC’s best and brightest health researchers and support the advancement of world-class health research in BC. The Scholar and Research Trainee Programs specifically support BC’s next generation of health researchers. This year’s awardees are
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
